In recent times cardiovascular diseases (CVDs) are the leading cause of mortality
universally, caused more or less 17.7 million casualties with 45% of all illnesses (except …

Antihypertensive agents‐Diuretics‐β‐blockers‐Calcium channel blockers‐Angiotensin
converting enzyme inhibitors‐Angiotensin receptor blockers‐ACEIs versus ARBs versus …

Cardiovascular diseases (CVD), including coronary heart disease (CHD), heart attacks,
stroke, heart failure (HF), and peripheral artery disease, still represent the leading cause of …

In the past 2 decades, significant progress has been made in cardiovascular therapeutics.
Effective drug therapies have been developed for hypertension, hypercholesterolemia …

The present book covers the basic principles of cardiovascular physiology, pathophysiology
and advanced pharmacology with particular emphasis on cellular mechanisms of drug …

Despite the major advancements in cardiovascular medicine over the past 50 years, heart
disease and stroke remain the number one public health concern and primary causes of …

Biologics are revolutionizing the treatment of chronic diseases, such as cancer and
monogenic disorders, by overcoming the limits of classic therapeutic approaches using …

Background Heart disease is the# 1 killer worldwide, greater than all cancers combined.
This is despite the fact that, in the developed world, there has been a substantial decline in …

Introduction espite the large number of pharmacologic agents available for the treatment of
cardiovascular disease, the search for additional drugs and pharmacotherapeutic …

Introduction Hypertension and cardiovascular diseases (CVD) are very common conditions
and account for significant medical disability and death worldwide. Therefore, their …